Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Erbliche Diabetesneigung

Die erbliche Diabetesneigung ist durch eine Reihe an genetischen Variationen in unterschiedlichen Genen definiert. Die Anfälligekeit für eine Entwicklung eines Typ 2 Diabetes schließt auch eine Insulinresistenz mit ein.

Gliederung

Diabetes mellitus
Diabetische Nephropathie
Diabetische Retinopathie
Erbliche Diabetesneigung
IRS1
MAPK8IP1
PDX1
SH2B1
TBC1D1
Gestationsdiabetes
Insulinresistenz
MODY Diabetes
Mitochondrialer Diabetes mellitus
Neonataler Diabetes mellitus
Nichtinsulinabhängiger Diabetes mellitus 1
Pankreopriver Diabetes mellitus
Schwere Fettsucht mit Typ 2 Diabetes
Suszeptibilität für Typ 1 Diabetes 01

Referenzen:

1.

Horikawa Y et al. (2008) Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan.

external link
2.

et. al. (2010) Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls.

external link
3.

Okamoto K et al. (2010) Identification of KCNJ15 as a susceptibility gene in Asian patients with type 2 diabetes mellitus.

external link
4.

Kong A et al. (2009) Parental origin of sequence variants associated with complex diseases.

external link
5.

Perry JR et al. (2010) Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes.

external link
6.

Ding EL et al. (2009) Sex hormone-binding globulin and risk of type 2 diabetes in women and men.

external link
7.

Lyssenko V et al. (2008) Clinical risk factors, DNA variants, and the development of type 2 diabetes.

external link
8.

Meigs JB et al. (2008) Genotype score in addition to common risk factors for prediction of type 2 diabetes.

external link
9.

Prokopenko I et al. (2008) Type 2 diabetes: new genes, new understanding.

external link
10.

Yasuda K et al. (2008) Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus.

external link
11.

Unoki H et al. (2008) SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations.

external link
12.

Onuma H et al. (2010) The GCKR rs780094 polymorphism is associated with susceptibility of type 2 diabetes, reduced fasting plasma glucose levels, increased triglycerides levels and lower HOMA-IR in Japanese population.

external link
13.

Dentin R et al. (2008) Hepatic glucose sensing via the CREB coactivator CRTC2.

external link
14.

van Vliet-Ostaptchouk JV et al. (2008) HHEX gene polymorphisms are associated with type 2 diabetes in the Dutch Breda cohort.

external link
15.

Sparsø T et al. (2008) The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes.

external link
16.

Matsuzaka T et al. (2007) Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance.

external link
17.

Aeberli I et al. (2007) Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children.

external link
18.

Sladek R et al. (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes.

external link
19.

Fuku N et al. (2007) Mitochondrial haplogroup N9a confers resistance against type 2 diabetes in Asians.

external link
20.

Shtir C et al. (2007) Subsets of Finns with high HDL to total cholesterol ratio show evidence for linkage to type 2 diabetes on chromosome 6q.

external link
21.

Martinez-Marignac VL et al. (2007) Admixture in Mexico City: implications for admixture mapping of type 2 diabetes genetic risk factors.

external link
22.

Graham TE et al. (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.

external link
23.

Gauguier D et al. (1996) Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes in the GK rat.

external link
24.

Tuomi T et al. (1999) Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.

external link
25.

Fonseca VA et al. (1998) Troglitazone monotherapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled study. The Troglitazone Study Group.

external link
26.

Pratley RE et al. (1998) An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians.

external link
27.

Poulton J et al. (1998) A common mitochondrial DNA variant is associated with insulin resistance in adult life.

external link
28.

Shimabukuro M et al. (1998) Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes.

external link
29.

Shimabukuro M et al. (1997) Leptin- or troglitazone-induced lipopenia protects islets from interleukin 1beta cytotoxicity.

external link
30.

Terauchi Y et al. (1997) Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease.

external link
31.

Brüning JC et al. (1997) Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles.

external link
32.

Lee Y et al. (1997) Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM.

external link
33.

Sreenan S et al. (1996) Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone.

external link
34.

Fajans SS et al. (2001) Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young.

external link
35.

Galli J et al. (1996) Genetic analysis of non-insulin dependent diabetes mellitus in the GK rat.

external link
36.

Lee Y et al. (1994) Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships.

external link
37.

Bogardus C et al. (1989) Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions.

external link
38.

et al. (2014) Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico.

external link
39.

Zhou K et al. (2012) The role of ATM in response to metformin treatment and activation of AMPK.

external link
40.

Woods A et al. (2012) The role of ATM in response to metformin treatment and activation of AMPK.

external link
41.

Yee SW et al. (2012) The role of ATM in response to metformin treatment and activation of AMPK.

external link
42.

Bonnefond A et al. (2012) Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes.

external link
43.

et al. (2011) Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes.

external link
44.

Woods A et al. (2011) LKB1 is required for hepatic bile acid transport and canalicular membrane integrity in mice.

external link
45.

Scott LJ et al. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.

external link
46.

Altshuler D et al. (2000) The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.

external link
47.

Fakhrai-Rad H et al. (2000) Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats.

external link
48.

Piatti PM et al. (2000) Alterations in nitric oxide/cyclic-GMP pathway in nondiabetic siblings of patients with type 2 diabetes.

external link
49.

Chung YS et al. (2000) HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients.

external link
50.

Elbein SC et al. (1999) A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians.

external link
51.

Elbein SC et al. (1999) Heritability of pancreatic beta-cell function among nondiabetic members of Caucasian familial type 2 diabetic kindreds.

external link
52.

Hanson RL et al. (1998) An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians.

external link
53.

Savage DB et al. (2002) Digenic inheritance of severe insulin resistance in a human pedigree.

external link
54.

Sandhu MS et al. (2007) Common variants in WFS1 confer risk of type 2 diabetes.

external link
55.

Zeggini E et al. (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.

external link
56.

Yang Q et al. (2005) Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.

external link
57.

et al. (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.

external link
58.

Mammarella S et al. (2000) Interaction between the G1057D variant of IRS-2 and overweight in the pathogenesis of type 2 diabetes.

external link
59.

None (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.

external link
60.

Babenko AP et al. (2006) Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.

external link
61.

Gudmundsson J et al. (2007) Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes.

external link
62.

Shimajiri Y et al. (2001) A missense mutation of Pax4 gene (R121W) is associated with type 2 diabetes in Japanese.

external link
63.

Illig T et al. (2004) Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes.

external link
64.

Möhlig M et al. (2004) Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes.

external link
65.

Triggs-Raine BL et al. (2002) HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community.

external link
66.

Halsall DJ et al. (2003) Typical type 2 diabetes mellitus and HFE gene mutations: a population-based case - control study.

external link
67.

Watanabe RM et al. (2000) The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. II. An autosomal genome scan for diabetes-related quantitative-trait loci.

external link
68.

Mohlke KL et al. (2005) Mitochondrial polymorphisms and susceptibility to type 2 diabetes-related traits in Finns.

external link
69.

Scheuner D et al. (2005) Control of mRNA translation preserves endoplasmic reticulum function in beta cells and maintains glucose homeostasis.

external link
70.

Maeda S et al. (2005) Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus.

external link
71.

Foti D et al. (2005) Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice.

external link
72.

O'Rahilly S et al. (1992) Multipoint linkage analysis of the short arm of chromosome 11 in non-insulin dependent diabetes including maturity onset diabetes of youth.

external link
73.

Do DV et al. (2005) Persistent diabetic macular edema is associated with elevated hemoglobin A1c.

external link
74.

Petersen KF et al. (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.

external link
75.

Martin BC et al. (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study.

external link
76.

Garber AJ et al. (2003) Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes.

external link
77.

Demenais F et al. (2003) A meta-analysis of four European genome screens (GIFT Consortium) shows evidence for a novel region on chromosome 17p11.2-q22 linked to type 2 diabetes.

external link
78.

Reynisdottir I et al. (2003) Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2.

external link
79.

Petersen KF et al. (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance.

external link
80.

van Tilburg JH et al. (2003) A genome-wide scan in type 2 diabetes mellitus provides independent replication of a susceptibility locus on 18p11 and suggests the existence of novel Loci on 2q12 and 19q13.

external link
81.

Poulton J et al. (2002) Type 2 diabetes is associated with a common mitochondrial variant: evidence from a population-based case-control study.

external link
82.

Mori Y et al. (2002) Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p.

external link
83.

Yuan M et al. (2001) Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta.

external link
84.

Aljada A et al. (2001) Nuclear factor-kappaB suppressive and inhibitor-kappaB stimulatory effects of troglitazone in obese patients with type 2 diabetes: evidence of an antiinflammatory action?

external link
85.

Li H et al. (2001) Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 Diabetes.

external link
86.

Hart AW et al. (2000) Attenuation of FGF signalling in mouse beta-cells leads to diabetes.

external link
87.

Vionnet N et al. (2000) Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24.

external link
88.

Ghosh S et al. (2000) The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes.

external link
89.

OMIM.ORG article

Omim 125853 external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz